Active Not RecruitingNCT06474195
Official study titleEffectiveness of Cue-based Intervention in Improving Prospective Memory by Enhancing Medication Adherence in Patients With Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial
This study is no longer accepting new participants.
In BengaluruSchizophreniaBehavioural studyAges 18–60
- Countries
- India
- Sponsor
- University of Pittsburgh
CompletedNCT01152697
Official study titleA Prospective Trial of Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic (CAE-L) in Individuals With Schizophrenia or Schizoaffective Disorder at Risk for Treatment Non-adherence and for Homelessness
This study has finished and is no longer accepting participants.
In ClevelandSchizophreniaMedication studyAges 18+
- Countries
- United States
- Sponsor
- University Hospitals Cleveland Medical Center
CompletedNCT05716802
Official study titleDance/Movement Therapy for Improving Bone Mineral Density in Long-term Patients With Schizophrenia: a Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In BaodingSchizophreniaBehavioural studyAges 40–60
- Countries
- China
- Sponsor
- Hebei Province Veterans Hospital
TerminatedNCT02361554
This study ended early.
In BaltimoreSchizophreniaDevice studyAges 22–65
- Countries
- United States
- Sponsor
- Johns Hopkins University
Active Not RecruitingNCT05337904
Official study titleDeep Brain Stimulation: Towards a Novel Intervention Focused on the Recovery of Patients With Treatment-Resistant Schizophrenia: Randomized, Controlled, Crossover Pilot Study
This study is no longer accepting new participants.
In BarcelonaSchizophreniaDevice studyAges 18–50
- Countries
- Spain
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
TerminatedNCT05724810
This study ended early.
In Stony BrookSchizophreniaDevice studyAges 18–60
- Countries
- United States
- Sponsor
- Stony Brook University
CompletedNCT04859504
Official study titleDual-channel Transcranial Alternating Current Stimulations Targeting Negative Symptoms in Schizophrenia Patients: a Randomized Clinical Trial
This study has finished and is no longer accepting participants.
Multiple locations, including ZhenjiangSchizophreniaDevice studyAges 18–60
- Countries
- China
- Sponsor
- Shanghai Mental Health Center
CompletedNCT05944510
Official study titleDextromethorphan as an Augmentation Agent in Treatment-resistant Schizophrenia: A Randomized, Group Sequential Adaptive Design, Controlled Clinical Trial
This study has finished and is no longer accepting participants.
In BhubaneswarSchizophreniaMedication studyAges 18+
- Countries
- India
- Sponsor
- All India Institute of Medical Sciences, Bhubaneswar
CompletedNCT01082289
Official study titleA Phase 1, Open-Label, Drug-Drug Interaction Study to Determine the Effect of Repeated Dose Lurasidone 120 mg Administration on the Pharmacokinetics of Orally Administered Digoxin 0.25 mg in Patients With Schizophrenia or Schizoaffective Disorder.
This study has finished and is no longer accepting participants.
In Culver CitySchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Sumitomo Pharma America, Inc.
CompletedNCT02782091
Official study titleValidation of an Ecological Assessment of Executive Function (Multiple Errands Test) in Patients With Schizophrenia : Study of Discriminant Validity
This study has finished and is no longer accepting participants.
In CréteilSchizophreniaBehavioural studyAges 18–50
- Countries
- France
- Sponsor
- Assistance Publique - Hôpitaux de Paris
CompletedNCT03652974
This study has finished and is no longer accepting participants.
In ShanghaiSchizophreniaMedication studyAges 18–60
- Countries
- China
- Sponsor
- Shanghai Mental Health Center
Active Not RecruitingNCT05748990
This study is no longer accepting new participants.
In TorontoSchizophreniaMedication studyAges 17–45
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health (Hospital / academic medical center)